BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25749265)

  • 1. Pharmacist provider status legislation: Projections and prospects.
    Harper PC
    J Am Pharm Assoc (2003); 2015; 55(2):203-7. PubMed ID: 25749265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Does Provider Status Mean for Pharmacists?
    Consult Pharm; 2015 Aug; 30(8):478-80. PubMed ID: 26260644
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathway to pharmacist medical provider status in Washington State.
    Hazlet TK; Karwaki TE; Downing DF
    J Am Pharm Assoc (2003); 2017; 57(1):116-119. PubMed ID: 27836482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist provider status: Geoprocessing analysis of pharmacy locations, medically underserved areas, populations, and health professional shortage areas.
    Murphy EM; West L; Jindal N
    J Am Pharm Assoc (2003); 2021; 61(6):651-660.e1. PubMed ID: 34531121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the cost of the Medicare Pharmacist Services Coverage Act of 2001.
    Poole VH; Moran DW; Webb CE
    Pharmacotherapy; 2003 Aug; 23(8):955-65. PubMed ID: 12921241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist Provider-Status Legislation Returns.
    Baldwin P
    Sr Care Pharm; 2021 Jul; 36(7):357. PubMed ID: 34144726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the 2009 APhA House of Delegates: actions of the legislative body of the American Pharmacists Association.
    J Am Pharm Assoc (2003); 2009; 49(4):492-4. PubMed ID: 19589759
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist 'provider status' legislation introduced into the Senate.
    Young D
    Am J Health Syst Pharm; 2003 Aug; 60(15):1502. PubMed ID: 12951746
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacists need recognition as providers to enhance patient care.
    White CM
    Ann Pharmacother; 2014 Feb; 48(2):268-73. PubMed ID: 24259647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy waste, fraud, and abuse in health care reform.
    Carpenter LA; Edgar Z; Dang C
    J Am Pharm Assoc (2003); 2011; 51(2):e3-16. PubMed ID: 21382799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population health and medicine: Policy and financial drivers.
    Lavigne JE; Brown J; Matzke GR
    Am J Health Syst Pharm; 2017 Sep; 74(18):1413-1421. PubMed ID: 28887343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic terminology in obtaining reimbursement for pharmacists' cognitive services.
    Nutescu EA; Klotz RS
    Am J Health Syst Pharm; 2007 Jan; 64(2):186-92. PubMed ID: 17215470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Washington: a nephrologist's perspective from inside the Beltway.
    Rubin RJ
    Am J Kidney Dis; 2013 Dec; 62(6):1042-5. PubMed ID: 24051080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why health reform will bend the cost curve.
    Cutler DM; Davis K; Stremikis K
    Issue Brief (Commonw Fund); 2009 Dec; 72():1-16. PubMed ID: 19998565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Getting Paid for Clinical Services.
    Martin CM
    Consult Pharm; 2018 May; 33(5):240-246. PubMed ID: 29789045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consortium recommendations for advancing pharmacists' patient care services and collaborative practice agreements.
    American Pharmacists Association Foundation and American Pharmacists Association
    J Am Pharm Assoc (2003); 2013; 53(2):e132-41. PubMed ID: 23571636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMS chief affirms incident-to billing for pharmacists is allowed.
    Traynor K
    Am J Health Syst Pharm; 2014 Jun; 71(12):977-8. PubMed ID: 24865750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.